Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Assay test kits
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Assay test kits

[0902-DK.009.05.3] abia Treponema Ab - 480 Tests
abia Treponema Ab - 480 Tests
180.00 € 180.0 EUR
[0902-DK.040.01.3] abia Testosterone - 96 tests
abia Testosterone - 96 tests
180.00 € 180.0 EUR
[0902-DK.035.01.3] abia T4 total - 96 tests
abia T4 total - 96 tests
180.00 € 180.0 EUR
[0902-DK.029.01.3] abia HEV IgG Elisa  - 96 Tests
abia HEV IgG Elisa - 96 Tests
195.00 € 195.0 EUR
[0902-DK.067.05.3] abia HCV Ab Elisa - 480 Tests
abia HCV Ab Elisa - 480 Tests
195.00 € 195.0 EUR
[0902-DK.013.05.3] abia HBsAg Elisa - 480 Tests
abia HBsAg Elisa - 480 Tests
165.00 € 165.0 EUR
[0639-abx298876-96T] Zinc Assay Test-96 tests
Zinc Assay Test-96 tests
700.00 € 700.0 EUR
[0855-ELK9663] Zebrafish IL6 (Interleukin 6) ELISA Test - 96 Tests
Zebrafish IL6 (Interleukin 6) ELISA Test - 96 Tests
348.00 € 348.0 EUR
[0855-ELK8508] Zebrafish IL10 (Interleukin 10) ELISA Test - 96 Tests
Zebrafish IL10 (Interleukin 10) ELISA Test - 96 Tests
389.00 € 389.0 EUR
[0878-LWBVTMCT03] Viral Transport Medium (Non-inactivated Type) - 100 Tests
Viral Transport Medium (Non-inactivated Type) - 100 Tests
863.00 € 863.0 EUR
[0905-IVCAB-625] Vibrio Cholera  O1/O139 Combo Rapid Test Cassette (Feces) - 10 Tests
Vibrio Cholera O1/O139 Combo Rapid Test Cassette (Feces) - 10 Tests
224.00 € 224.0 EUR
[0037-30086-T] ViaFluor® SE Cell Proliferation Tests - Trial size (1 vial), ViaFluor® 488
ViaFluor® SE Cell Proliferation Tests - Trial size (1 vial), ViaFluor® 488
430.00 € 430.0 EUR
[0037-30086] ViaFluor® SE Cell Proliferation Tests - Set of 10 vials, ViaFluor® 488
ViaFluor® SE Cell Proliferation Tests - Set of 10 vials, ViaFluor® 488
600.00 € 600.0 EUR
[0832-11-1250] Venor®GeM Classic Mollicutes (Mycoplasma, Acholeplasma, Spiroplasma) detection Test - 250 tests
Venor®GeM Classic Mollicutes (Mycoplasma, Acholeplasma, Spiroplasma) detection Test - 250 tests
1,414.00 € 1414.0 EUR
[0832-370-2100] Vegan Control 100 tests qPCR-based screening of animal DNA in food
Vegan Control 100 tests qPCR-based screening of animal DNA in food
1,657.00 € 1657.0 EUR
[0905-IVPH-504H] Vaginal pH Rapid Test Panel(Vaginal Swab) For Self-testing,  200X1tests
Vaginal pH Rapid Test Panel(Vaginal Swab) For Self-testing, 200X1tests
450.00 € 450.0 EUR
[0536-LIO-920571] VANCOMYCIN- 10 tests
VANCOMYCIN- 10 tests
122.06 € 122.06 EUR
[0617-EKU08751-96T] Uridine Triphosphate (UTP) ELISA Test - 96 Tests
Uridine Triphosphate (UTP) ELISA Test - 96 Tests
1,400.00 € 1400.0 EUR
[0848-CoV2Ag-25] UnScience Covid-19 Antigen Test - 25 Tests
UnScience Covid-19 Antigen Test - 25 Tests
35.00 € 35.0 EUR
[0198-CTNI-2-US] ULTRA-SENSITIVE RAT CARDIAC TROPONIN-I ELISA, 96 tests
ULTRA-SENSITIVE RAT CARDIAC TROPONIN-I ELISA, 96 tests
809.00 € 809.0 EUR
  • 34
  • 35
  • 36
  • 37
  • 38

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)